Jeff Hartness

Jeff Hartness is a dynamic pharmaceutical, healthcare and biotech senior executive with more than 25 years of leadership and sustained success in creating and executing go-to-market strategies. He has launched dozens of products in a multitude of disease states including small molecules, specialty/biologics, devices, OTCs and generics.

Mr. Hartness is currently a member of Bausch Health Company’s (BHC) Global Executive Committee as Senior Vice President and Head of Market Access, Commercial Operations, Policy and Government Affairs. He focuses on the commercialization strategy of pricing, contracting and the creation of patient access to Bausch Health products, as well as the distribution of those products throughout the healthcare system.

Prior to joining Bausch Health, Mr. Hartness spent 15 years at Sanofi (SNY) in various leadership roles, including Product Launch Execution and as the Head of Pharmacy Benefit Managers, Employers and Specialty business. Mr. Hartness currently serves on the Board of Directors for Corganics, a privately held clinical cannabinoid life sciences company based in Dallas, Texas.

Jeff’s diverse background crosses all channels and segments of the pharmaceutical business making him a perfect fit to join the Bryn Pharma team.